MediciNova, Inc. (MNOV)
1.41
-0.02
(-1.40%)
USD |
NASDAQ |
May 08, 14:20
MediciNova Research and Development Expense (Annual) : 7.135M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Biogen, Inc. | 1.481B |
| Cytokinetics, Inc. | 405.90M |
| Ionis Pharmaceuticals, Inc. | 913.18M |
| Zimmer Biomet Holdings, Inc. | 458.50M |
| Amylyx Pharmaceuticals, Inc. | 89.88M |